R. Reynolds

Cardiovascular safety of fexofenadine HCl

A. Brown, C. Pratt, D. Rampe, 1999, Clinical and Experimental Allergy.

Cardiovascular safety of fexofenadine HCl.

C. Pratt, J. Mason, T. Russell, 1999, The American journal of cardiology.

Pharmacokinetics of icodextrin in peritoneal dialysis patients.

S. Mujais, R. Hamburger, J. Moberly, 2002, Kidney international. Supplement.

Directly observed therapy for the management of HIV-infected patients in a methadone program.

B. Conway, R. Reynolds, A. Mead, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.

P. Howarth, J. Bousquet, L. Roi, 1999, The Journal of allergy and clinical immunology.

Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.

H. Nelson, J. Mason, R. Reynolds, 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Asthma, rhinitis, other respiratory diseases Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis

P. Howarth, J. Bousquet, L. Roi, 1999 .

The systemic safety of fexofenadine HCl

J. Mason, R. Reynolds, N. Rao, 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

The Effect of Renal Insufficiency and Hemodialysis on the Pharmacokinetics of Nalmefene

R. Frye, R. Rault, G. Matzke, 1996, Journal of clinical pharmacology.